Trv Gp Iv
Latest statistics and disclosures from Trv Gp Iv's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MAZE, TNGX, and represent 100.00% of Trv Gp Iv's stock portfolio.
- Trv Gp Iv has $254M in assets under management (AUM), dropping by -4.95%.
- Central Index Key (CIK): 0001688325
Tip: Access up to 7 years of quarterly data
Positions held by Trv Gp Iv consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Trv Gp Iv
Trv Gp Iv holds 2 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Maze Therapeatics (MAZE) | 52.6 | $134M | 4.5M | 29.84 |
|
|
| Tango Therapeutics (TNGX) | 47.4 | $120M | 6.4M | 18.85 |
|
Past Filings by Trv Gp Iv
SEC 13F filings are viewable for Trv Gp Iv going back to 2018
- Trv Gp Iv 2026 Q2 filed Aug. 10, 2026
- Trv Gp Iv 2026 Q1 filed May 7, 2026
- Trv Gp Iv 2025 Q4 filed Feb. 13, 2026
- Trv Gp Iv 2025 Q3 filed Nov. 13, 2025
- Trv Gp Iv 2025 Q2 filed Aug. 8, 2025
- Trv Gp Iv 2025 Q1 filed May 9, 2025
- Trv Gp Iv 2024 Q4 filed Feb. 13, 2025
- Trv Gp Iv 2024 Q3 filed Nov. 6, 2024
- Trv Gp Iv 2024 Q2 filed Aug. 9, 2024
- Trv Gp Iv 2024 Q1 filed May 13, 2024
- Trv Gp Iv 2023 Q4 filed Feb. 14, 2024
- Trv Gp Iv 2023 Q3 filed Nov. 13, 2023
- Trv Gp Iv 2023 Q2 filed Aug. 10, 2023
- Trv Gp Iv 2023 Q1 filed May 12, 2023
- Trv Gp Iv 2022 Q4 filed Feb. 14, 2023
- Trv Gp Iv 2022 Q3 filed Nov. 3, 2022